Myeloma Experts Continue To Answer Questions At The Myeloma Beacon Forums – The Mayo Clinic, represented by myeloma expert Dr. Martha Lacy, will be answering medical questions posted to the forums at the Myeloma Beacon this week. Readers are encouraged to post their questions to the Myeloma Beacon Forums.

MannKind Receives MMRF Grant For Development Of New Myeloma Treatment – The Multiple Myeloma Research Foundation (MMRF) and MannKind, a biopharmaceutical company based in Valencia, CA, announced today that the MMRF will award MannKind $1 million for the development of a new compound for the treatment of multiple myeloma. The new compound, an IRE-1a inhibitor, inhibits growth of tumor cells, which may in turn make the cancer cells more susceptible to common myeloma treatments.  The award is based on results from nonclinical studies. For more information, please see the MannKind press release.

The MMRF Holds Free Myeloma Symposium – On April 9, the Multiple Myeloma Research Foundation (MMRF) will hold a free educational symposium for multiple myeloma patients, their family members and caregivers about the latest advances and treatments in multiple myeloma. The event will take place at the Grand Hyatt in New York, NY from 10 a.m. to 4 p.m. Please see the MMRF Web site to register.

For a more detailed listing of myeloma related events, please check the Myeloma Beacon Events Calendar.